GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Venus Remedies Ltd (BOM:526953) » Definitions » Other Income (Expense)

Venus Remedies (BOM:526953) Other Income (Expense) : ₹90 Mil (TTM As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Venus Remedies Other Income (Expense)?

Venus Remedies's other income expense for the Venus Remedies's pretax income for the three months ended in Dec. 2023 was ₹24 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2023 was ₹90 Mil.

Venus Remedies Other Income (Expense) Historical Data

The historical data trend for Venus Remedies's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Venus Remedies Other Income (Expense) Chart

Venus Remedies Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -57.69 -106.95 429.50 73.88 83.89

Venus Remedies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.10 13.49 22.60 30.50 23.50

Venus Remedies Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹90 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Venus Remedies  (BOM:526953) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Venus Remedies (BOM:526953) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Venus Remedies Ltd (BOM:526953) » Definitions » Other Income (Expense)
Comparable Companies
BOM:539997 BOM:530477 BOM:541096 BOM:524654 BOM:539730 BOM:532408 BOM:524500 BOM:532039 BOM:500009 NSE:MADHAVBAUG ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
VENUSREM:India
Address
Plot 51-52, Industrial Area, Phase 1, Panchkula, HR, IND, 134113
Website
https://www.venusremedies.com
Venus Remedies Ltd is an Indian drug manufacturer. It is engaged in manufacturing and trading pharmaceutical products. The company produces biologically active food supplements which include food supplements are natural complexes containing minerals, vitamins, dietary fibers, extracts of medicinal herbs, amino acids, and others.

Venus Remedies (BOM:526953) Headlines

No Headlines